3.61
전일 마감가:
$3.70
열려 있는:
$3.7
하루 거래량:
998.78K
Relative Volume:
0.67
시가총액:
$537.69M
수익:
$389.42M
순이익/손실:
$30.70M
주가수익비율:
17.67
EPS:
0.2043
순현금흐름:
$67.23M
1주 성능:
-0.82%
1개월 성능:
+1.40%
6개월 성능:
-49.08%
1년 성능:
-38.29%
Mimedx Group Inc Stock (MDXG) Company Profile
명칭
Mimedx Group Inc
전화
(770) 651-9100
주소
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
2.33 | 3.33B | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.79 | 397.06M | 52.15M | -21.46M | 0 | -0.4675 |
|
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
2.77 | 254.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.74 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 개시 | Citizens | Mkt Outperform |
| 2024-07-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-07 | 개시 | Lake Street | Buy |
| 2023-10-27 | 개시 | Craig Hallum | Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-07-26 | 개시 | Northland Capital | Outperform |
| 2021-03-19 | 개시 | H.C. Wainwright | Buy |
모두보기
Mimedx Group Inc 주식(MDXG)의 최신 뉴스
MiMedx (NASDAQ: MDXG) awards 50,913 restricted shares to director - Stock Titan
Director Dorothy Puhy granted 50,913 MDXG shares in annual stock award - Stock Titan
MIMEDX (NASDAQ: MDXG) awards 50,913 restricted shares to director Todd Newton - Stock Titan
MIMEDX (MDXG) director William Hawkins receives 50,913-share restricted stock grant - Stock Titan
MiMedx (NASDAQ: MDXG) director Tiffany Olson receives 50,913-share stock grant - Stock Titan
How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets - Yahoo Finance
MDXG PE Ratio & Valuation, Is MDXG Overvalued - Intellectia AI
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - PR Newswire
Senior MiMedx execs heading to Craig-Hallum investor event - Stock Titan
MiMedx Group stock (US60251E1029): earnings turnaround and wound-care demand in focus - AD HOC NEWS
MiMedx Group (MDXG) price target decreased by 18.75% to 6.63 - MSN
About Us | Oil & Gas JournalMiMedx Group, IncCommon Stock (Nasdaq:MDXG) Stock Quote - FinancialContent
MDXG stock rises as MiMedx enters into exclusive distribution agreement for three products - MSN
Is the Options Market Predicting a Spike in MiMedx Group Stock? - sharewise.com
MiMedx: The Hard Math Behind My Downgrade To Hold - Seeking Alpha
MiMedx launches G4Derm Plus wound care product nationwide By Investing.com - Investing.com Australia
MiMedx launches G4Derm Plus wound care product nationwide - Investing.com
MIMEDX Announces Launch of G4Derm® Plus - The Manila Times
New wound-care matrix heads to hospitals via Premier, Vizient - Stock Titan
Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings - Yahoo Finance
How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative - Yahoo Finance
U.S. Perinatal Tissue-derived Allograft Market Detailed In New - openPR.com
MSN Money - MSN
MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
MiMedx Launches CHORIOFIX Placental Allograft for Complex Wound Care - HarianBasis.co
MiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by Wall Street Zen - MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7%Still a Buy? - MarketBeat
MiMedx Reports Q1 Revenue Drop Amid Medicare Reimbursement Shift - HarianBasis.co
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds - Insider Monkey
Citizens cuts MiMedx stock price target to $6 on Medicare headwinds By Investing.com - Investing.com India
MiMedx Group (MDXG) price target decreased by 17.24% to 8.16 - MSN
MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $6.00 at Citizens Jmp - MarketBeat
Q1 2026 MiMedx Group Inc Earnings Call Transcript - GuruFocus
New Medicare payment rules hit MIMEDX wound sales 60%, cut 2026 view - Stock Titan
Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption - MSN
Citizens cuts MiMedx stock price target to $6 on Medicare headwinds - Investing.com Australia
MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Naviga - GuruFocus
MiMedx Group (MDXG) Faces Challenges Amid Surgical Growth in Q1 2026 - GuruFocus
Mimedx Group Inc (MDXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mimedx Group Inc 주식 (MDXG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '26 |
Option Exercise |
4.50 |
136,364 |
613,638 |
624,900 |
| DOUG RICE | Chief Financial Officer |
Mar 10 '26 |
Option Exercise |
4.50 |
243,000 |
1,093,500 |
508,678 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Nov 06 '25 |
Sale |
7.42 |
58,300 |
432,329 |
236,982 |
자본화:
|
볼륨(24시간):